
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TELA market cap is 67.24M. The company's latest EPS is USD -0.9567 and P/E is -1.81.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 16.6M | 16.09M | 18.96M | 17.65M | 18.52M |
Operating Income | -12.41M | -11.57M | -9.37M | -8.35M | -10.47M |
Net Income | -5.66M | -12.6M | -10.37M | -9.21M | -11.26M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 18.21M | 29.46M | 41.42M | 58.45M | 69.3M |
Operating Income | -25.28M | -29.45M | -39.01M | -44.08M | -41.7M |
Net Income | -28.79M | -33.28M | -44.3M | -46.66M | -37.84M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 71.84M | 60.2M | 53.02M | 86.57M | 77.25M |
Total Liabilities | 57.45M | 57.33M | 59.29M | 58.11M | 59.13M |
Total Equity | 14.38M | 2.87M | -6.27M | 28.46M | 18.12M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 86.46M | 62.54M | 67.86M | 78.05M | 86.57M |
Total Liabilities | 37.43M | 42.45M | 53.55M | 59.17M | 58.11M |
Total Equity | 49.03M | 20.1M | 14.31M | 18.88M | 28.46M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -14.38M | -25.08M | -34.06M | -41.6M | -9.73M |
Investing | 4.7M | 4.76M | 4.64M | 4.45M | 138k |
Financing | 56k | 51k | 149k | 43.06M | -116k |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -24.46M | -30.43M | -40.75M | -40.86M | -41.6M |
Investing | 9.12M | -627k | -1.87M | -599k | 4.45M |
Financing | 44.41M | 585k | 40.85M | 46.27M | 43.06M |
Market Cap | 67.24M |
Price to Earnings Ratio | -1.81 |
Price to Sales Ratio | 0.99 |
Price to Cash Ratio | 1.3 |
Price to Book Ratio | 2.4 |
Dividend Yield | - |
Shares Outstanding | 39.55M |
Average Volume (1 week) | 123.13k |
Average Volume (1 Month) | 202.78k |
52 Week Change | -69.64% |
52 Week High | 5.73 |
52 Week Low | 0.8645 |
Spread (Intraday) | 0.28 (16%) |
Company Name | TELA Bio Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.telabio.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions